AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
Modulation of 11 beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: An autocrine switch from glucocorticoid inactivation to activation
Authors: Cooper, MS Bujalska, I Rabbitt, E Walker, EA Bland, R Sheppard, MC Hewison, M Stewart, PM
Citation: Ms. Cooper et al., Modulation of 11 beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: An autocrine switch from glucocorticoid inactivation to activation, J BONE MIN, 16(6), 2001, pp. 1037-1044
Expression of 11 beta-hydroxysteroid dehydrogenase in rat osteoblastic cells: Pre-receptor regulation of glucocorticoid responses in bone
Authors: Eyre, LJ Rabbitt, EH Bland, R Hughes, SV Cooper, MS Sheppard, MC Stewart, PM Hewison, M
Citation: Lj. Eyre et al., Expression of 11 beta-hydroxysteroid dehydrogenase in rat osteoblastic cells: Pre-receptor regulation of glucocorticoid responses in bone, J CELL BIOC, 81(3), 2001, pp. 453-462
Weight gain following treatment of hyperthyroidism
Authors: Dale, J Daykin, J Holder, R Sheppard, MC Franklyn, JA
Citation: J. Dale et al., Weight gain following treatment of hyperthyroidism, CLIN ENDOCR, 55(2), 2001, pp. 233-239
An audit of management of differentiated thyroid cancer in specialist and non-specialist clinic settings
Authors: Kumar, H Daykin, J Holder, R Watkinson, JC Sheppard, MC Franklyn, JA
Citation: H. Kumar et al., An audit of management of differentiated thyroid cancer in specialist and non-specialist clinic settings, CLIN ENDOCR, 54(6), 2001, pp. 719-723
Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study
Authors: Parle, JV Maisonneuve, P Sheppard, MC Boyle, P Franklyn, JA
Citation: Jv. Parle et al., Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study, LANCET, 358(9285), 2001, pp. 861-865
Premature mortality and hypopituitarism - Authors' reply
Authors: Stewart, PM Tomlinson, JW Bates, AS Clayton, AN Sheppard, MC
Citation: Pm. Stewart et al., Premature mortality and hypopituitarism - Authors' reply, LANCET, 357(9272), 2001, pp. 1973-1974
Association between premature mortality and hypopituitarism
Authors: Tomlinson, JW Holden, N Hills, RK Wheatley, K Clayton, RN Bates, AS Sheppard, MC Stewart, PM
Citation: Jw. Tomlinson et al., Association between premature mortality and hypopituitarism, LANCET, 357(9254), 2001, pp. 425-431
Radioiodine treatment of hyperthyroidism - Prognostic factors for outcome
Authors: Allahabadia, A Daykin, J Sheppard, MC Gough, SCL Franklyn, JA
Citation: A. Allahabadia et al., Radioiodine treatment of hyperthyroidism - Prognostic factors for outcome, J CLIN END, 86(8), 2001, pp. 3611-3617
Tie-2 is expressed on thyroid follicular cells, is increased in colter, and is regulated by thyrotropin through cyclic adenosine 3 ',5 '-monophosphate
Authors: Ramsden, JD Cocks, HC Shams, M Nijjar, S Watkinson, JC Sheppard, MC Ahmed, A Eggo, MC
Citation: Jd. Ramsden et al., Tie-2 is expressed on thyroid follicular cells, is increased in colter, and is regulated by thyrotropin through cyclic adenosine 3 ',5 '-monophosphate, J CLIN END, 86(6), 2001, pp. 2709-2716
Follow-up of treated acromegaly: similarities and differences in assessingthe response to different primary treatment modalities
Authors: Sheppard, MC
Citation: Mc. Sheppard, Follow-up of treated acromegaly: similarities and differences in assessingthe response to different primary treatment modalities, GROWTH H I, 10, 2000, pp. 115-118
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant
Authors: Trainer, PJ Drake, WM Katznelson, L Freda, PU Herman-Bonert, V van der Lely, AJ Dimaraki, EV Stewart, PM Friend, KE Vance, ML Besser, GM Scarlett, JA Thorner, MO Parkinson, C Klibanski, A Powell, JS Barkan, AL Sheppard, MC Maldonado, M Rose, DR Clemmons, DR Johannson, G Bengtsson, BA Stavrou, S Kleinberg, DL Cook, DM Phillips, LS Bidlingmaier, M Strasburger, CJ Hackett, S Zib, K Bennett, WF Davis, RJ
Citation: Pj. Trainer et al., Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant, N ENG J MED, 342(16), 2000, pp. 1171-1177
Apoptosis during goitre involution - the role of Bcl-2
Authors: Patel, VA Hill, DJ Sheppard, MC Wang, JF Logan, A Eggo, MC
Citation: Va. Patel et al., Apoptosis during goitre involution - the role of Bcl-2, J ENDOCR, 164(3), 2000, pp. 323-330
Age and gender predict the outcome of treatment for Graves' hyperthyroidism
Authors: Allahabadia, A Daykin, J Holder, RL Sheppard, MC Gough, SCL Franklyn, JA
Citation: A. Allahabadia et al., Age and gender predict the outcome of treatment for Graves' hyperthyroidism, J CLIN END, 85(3), 2000, pp. 1038-1042
The renal expression of transforming growth factor-beta isoforms and theirreceptors in acute and chronic experimental diabetes in rats
Authors: Hill, C Flyvbjerg, A Gronbaek, H Petrik, J Hill, DJ Thomas, CR Sheppard, MC Logan, A
Citation: C. Hill et al., The renal expression of transforming growth factor-beta isoforms and theirreceptors in acute and chronic experimental diabetes in rats, ENDOCRINOL, 141(3), 2000, pp. 1196-1208
Outcome of surgery for acromegaly - the experience of a dedicated pituitary surgeon
Authors: Gittoes, NJL Sheppard, MC Johnson, AP Stewart, PM
Citation: Njl. Gittoes et al., Outcome of surgery for acromegaly - the experience of a dedicated pituitary surgeon, QJM-MON J A, 92(12), 1999, pp. 741-745
Mortality and hypopituitarism
Authors: Stewart, PM Sheppard, MC
Citation: Pm. Stewart et Mc. Sheppard, Mortality and hypopituitarism, GROWTH H I, 9, 1999, pp. 15-19
The interleukin-1 receptor antagonist gene shows no allelic association with three autoimmune diseases
Authors: Heward, J Allahabadia, A Gordon, C Sheppard, MC Barnett, AH Franklyn, JA Gough, SCL
Citation: J. Heward et al., The interleukin-1 receptor antagonist gene shows no allelic association with three autoimmune diseases, THYROID, 9(6), 1999, pp. 627-628
Sharing of susceptibility loci between autoimmune diseases: Lack of association of the insulin gene region with Graves' disease
Authors: Allahabadia, A Heward, J Carr-Smith, J Daykin, J Barnett, AH Sheppard, MC Franklyn, JA Gough, SCL
Citation: A. Allahabadia et al., Sharing of susceptibility loci between autoimmune diseases: Lack of association of the insulin gene region with Graves' disease, THYROID, 9(3), 1999, pp. 317-318
Gender, clinical findings, and serum thyrotropin measurements in the prediction of thyroid neoplasia in 1005 patients presenting with thyroid enlargement and investigated by fine-needle aspiration cytology
Authors: Kumar, H Daykin, J Holder, R Watkinson, JC Sheppard, MC Franklyn, JA
Citation: H. Kumar et al., Gender, clinical findings, and serum thyrotropin measurements in the prediction of thyroid neoplasia in 1005 patients presenting with thyroid enlargement and investigated by fine-needle aspiration cytology, THYROID, 9(11), 1999, pp. 1105-1109
Association of the large multifunctional proteasome (LMP2) gene with Graves' disease is a result of linkage disequilibrium with the HLA haplotype DRB10304-DQB1*O2-DQA1*0501
Authors: Heward, JM Allahabadia, A Sheppard, MC Barnett, AH Franklyn, JA Gough, SCL
Citation: Jm. Heward et al., Association of the large multifunctional proteasome (LMP2) gene with Graves' disease is a result of linkage disequilibrium with the HLA haplotype DRB10304-DQB1*O2-DQA1*0501, CLIN ENDOCR, 51(1), 1999, pp. 115-118
Increased MEN1 mRNA expression in sporadic pituitary tumours
Authors: McCabe, CJ Gittoes, NJL Sheppard, MC Franklyn, JA
Citation: Cj. Mccabe et al., Increased MEN1 mRNA expression in sporadic pituitary tumours, CLIN ENDOCR, 50(6), 1999, pp. 727-733
Prevalence and clinical usefulness of thyroid antibodies in different disease states of the thyroid
Authors: Kumar, H Daykin, J Betteridge, J Holder, R Sheppard, MC Franklyn, JA
Citation: H. Kumar et al., Prevalence and clinical usefulness of thyroid antibodies in different disease states of the thyroid, CLIN ENDOCR, 50(5), 1999, pp. 679-680
Clinical and biochemical response following withdrawal of a long-acting, depot injection form of octreotide (Sandostatin-LAR (R))
Authors: Stewart, PM Stewart, SE Clark, PMS Sheppard, MC
Citation: Pm. Stewart et al., Clinical and biochemical response following withdrawal of a long-acting, depot injection form of octreotide (Sandostatin-LAR (R)), CLIN ENDOCR, 50(3), 1999, pp. 295-299
Life expectancy following surgery for pituitary tumours
Authors: Bates, AS Bullivant, B Sheppard, MC Stewart, PM
Citation: As. Bates et al., Life expectancy following surgery for pituitary tumours, CLIN ENDOCR, 50(3), 1999, pp. 315-319
Characterization of 11 beta-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines
Authors: Bland, R Worker, CA Noble, BS Eyre, LJ Bujalska, IJ Sheppard, MC Stewart, PM Hewison, M
Citation: R. Bland et al., Characterization of 11 beta-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines, J ENDOCR, 161(3), 1999, pp. 455-464
Risultati: 1-25 | 26-28